DEA Bans Mind-Bending 3-MeO-PCP in Schedule I Crackdown
Published Date: 3/23/2026
Rule
Summary
Starting April 22, 2026, the DEA is putting 3-methoxyphencyclidine (3-MeO-PCP) into Schedule I, meaning it’s now officially a highly controlled substance with strict rules. This affects anyone who makes, sells, studies, or even possesses 3-MeO-PCP, who will face serious legal consequences. This move helps the U.S. follow international drug laws and keeps communities safer.
Analyzed Economic Effects
5 provisions identified: 1 benefits, 4 costs, 0 mixed.
3‑MeO‑PCP Placed Into Schedule I
Starting April 22, 2026, the Drug Enforcement Administration places 3-methoxyphencyclidine (3-MeO-PCP) in Schedule I of the Controlled Substances Act. That means possession, manufacture, distribution, importation, exportation, or other handling of 3-MeO-PCP is subject to the strict criminal, civil, and administrative penalties that apply to Schedule I substances.
DEA Registration Required to Handle 3‑MeO‑PCP
If you handle 3-MeO-PCP (manufacture, distribute, research with, import, export, or possess), you must register with DEA under 21 U.S.C. 822, 823, 957, and 958 and follow 21 CFR parts 1301 and 1312. Any person who currently handles 3-MeO-PCP and is not registered must submit an application and may not continue to handle it unless DEA approves the registration before the effective date.
Strict Compliance Rules for Registrants
DEA registrants handling 3-MeO-PCP must follow Schedule I controls including security requirements, labeling and packaging rules, quotas for manufacture, and recordkeeping and reporting. Registrants must take an initial inventory on the date they first handle controlled substances and thereafter inventory all controlled substances (including 3-MeO-PCP) every two years, and must comply with disposal rules and order form, import/export, and quota requirements.
Research Allowed but Requires Schedule I Registration
The final rule states that placing 3-MeO-PCP in Schedule I does not preclude research, but researchers must comply with DEA's Schedule I registration processes and requirements to conduct research legally. Those who wish to study 3-MeO-PCP must follow the DEA registration process for Schedule I substances before engaging in research.
DEA Says Limited Small‑Entity Economic Impact
DEA certifies under the Regulatory Flexibility Act that this final rule will not have a significant economic impact on a substantial number of small entities. The agency notes there appear to be no legitimate marketed sources for 3-MeO-PCP in the U.S., though legitimate suppliers sell it for scientific research, and there is no evidence of significant diversion from legitimate suppliers.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-06521 — Importer of Controlled Substances Application: Lipomed/LGC Standards
Lipomed/LGC Standards wants to become an official importer of certain controlled substances, like 3-Fluoro-N-methylcathinone. This means companies involved with these drugs can comment or ask for a hearing by May 4, 2026. If approved, it could impact how these substances enter the U.S., but no direct costs are mentioned yet.
2026-06523 — Designation of P2P Methyl Glycidic Acid as a List I Chemical
Starting May 4, 2026, anyone handling P2P methyl glycidic acid—a key chemical used to make illegal drugs like methamphetamine—must follow new government rules and register with the DEA. This means all transactions, big or small, will be closely watched to stop illegal drug production. Businesses dealing with this chemical should act fast to stay legal and avoid penalties.
2026-06051 — Importer of Controlled Substances Application: Usona Institute
Usona Institute wants to become an official importer of some powerful controlled substances like mescaline and psilocybin. People who make or use these drugs can share their thoughts or ask for a hearing by April 29, 2026. This move could impact research and medical use, with no direct cost changes announced yet.
2026-05912 — Bulk Manufacturer of Controlled Substances Application: SpecGx LLC
SpecGx LLC wants to become a big-time maker of some powerful and tightly controlled drugs, including things like psilocybin and fentanyl. People and companies already registered can share their thoughts or ask for a hearing by May 26, 2026. This move could shake up how these substances are made and handled, so keep an eye on the deadlines if you’re involved!
2026-05486 — Exempt Chemical Preparations Under the Controlled Substances Act
The Drug Enforcement Administration (DEA) just updated which chemical mixes are officially exempt from strict drug rules between September 2024 and December 2025. Companies and labs using these chemicals should check the new list to see if their products are approved or denied. You’ve got until May 19, 2026, to share your thoughts, and no extra fees are involved—just a quick review and comment if you want!
2026-05482 — Ordering Schedule I and II Controlled Substances Using DEA Form 222; Technical Amendments
If you order Schedule I or II drugs using DEA Form 222, this update clears up who can sign and manage the form—only registrants, their partners, or officers can do it. It also removes old rules about the old triplicate form, making things simpler and clearer. These fixes don’t change any big rules and take effect on March 20, 2026, so no extra costs or hassles ahead!
Previous / Next Documents
Previous: 2026-05607 — Air Plan Approval; Texas; Reasonably Available Control Technology in the Dallas-Fort Worth Ozone Nonattainment Area
The EPA is giving a thumbs-up to Texas’ updated air pollution rules for big factories in the Dallas-Fort Worth area to help cut smog-causing chemicals. These changes kick in on April 22, 2026, and aim to make the air cleaner without breaking the bank. If you’re a business owner or live in DFW, expect better air and smarter pollution controls soon!
Next: 2026-05634 — Minor Child Definition for Form LM-30 Labor Organization Officer and Employee Report
The Department of Labor is changing the definition of a “minor child” on the Form LM-30 from under 21 years old to under 18 years old. This update affects labor union officers and employees who file these reports, making it easier to comply without losing important financial disclosure info. The new rule kicks in April 22, 2026, for reports covering fiscal years starting July 1, 2026, with no extra costs involved.
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in